Age/sex | | | | | | | | | | | |
Fetal age (WG) | 21 | 21 | 23 | 23 | 28 | 29 | 29 | 29 | 32 | 36 | 27.1 |
Sex | M | M | M | M | M | M | F | M | F | F | 7M/3F† |
Maternal age | 35 | 26 | 32 | 30 | 24 | 31 | 37 | 31 | 28 | 31 | 30.5 |
Paternal age | 30 | 35 | 41 | 30 | 38 | 39 | 39 | 46 | 28 | 31 | 35.7† |
Genetics | | | | | | | | | | | |
Karyotype | 46,XY | 46,XY | 46,XY | 46,XY | 46,XY | 46,XY | 46,XX | 46,XY | 46,XX | 46,XX | |
FISH 22q11.2 (Tuple1) | N | N | N | N | N | N | N | N | N | N | |
CHD7 nucleotide change | 2550_2554del | 2959C>T | 763C>T | 6157C>T | 4112_4113insT | 808delG | 5458C>T | 2959C>T | 2260_2266dup | 2584A>T | 100% |
CHD7 protein change | K850fsX855 | R987X | Q255X | Arg2053X | N1371fsX1374 | A270fsX304 | P1820X | R987X | V754fsX764 | K862X | 100% |
De novo? | Yes | ? | Yes | ? | ? | Yes | Yes | Yes | Yes | Yes | |
CHARGE acronym | | | | | | | | | | | |
Coloboma | + | + | + | + | − | − | + | + | + | − | 70% |
Heart malformations | + | + | + | + | + | + | + | + | + | − | 90% |
Atresia choanal/cleft | AC | Cl | AC/Cl | Cl | Cl | − | AC/Cl | AC | AC | AC | 90% |
AC unilateral/bilateral | B | | U | | | | U | B | B | B | |
Cleft palate/lip | | L+P | P | L+P | P | | L+P | | | | |
CNS anomalies | | | | | | | | | | | |
Arhinencephaly | + | + | + | + | + | + | + | + | + | + | 100% |
Others CNS anomalies | + | + | + | + | + | + | + | + | − | − | 80% |
Genital anomalies | − | +* | − | + | +* | +* | + | + | − | − | 60% |
Ears | | | | | | | | | | | |
Anomalies of external ears | + | + | + | + | + | + | + | + | + | + | 100% |
Agenesis/hypoplasia CSC | + | + | + | + | + | + | + | + | + | + | 100% |
Others | | | | | | | | | | | |
Thymic hypo/agenesis | + | + | − | − | + | − | + | + | + | + | 70% |
Limb anomalies | + | + | − | − | − | − | + | − | + | + | 50% |
Renal anomalies | − | − | − | + | − | + | + | − | − | + | 40% |
Skeletal anomalies | + | + | ? | − | − | + | − | − | + | − | 40% |
Polyhydramnios | − | − | − | − | − | + | − | − | + | + | 30% |
Oesophageal anomalies | − | − | − | − | − | − | − | − | + | + | 20% |
IUGR | − | − | − | − | − | − | − | − | − | − | 0% |